Healthcare [ 13/13 ] | Medical Devices [ 113/164 ]
NASDAQ | Common Stock
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States.
The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.
It serves interventional radiologists, interventional cardiologists, and vascular surgeons.
The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013.
Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 30, 24 | -0.22 Decreased by -450.00% | -0.20 Decreased by -10.00% |
| Feb 28, 24 | -0.08 Increased by +27.27% | 0.01 Decreased by -900.00% |
| Nov 1, 23 | 0.05 Increased by +126.32% | -0.01 Increased by +600.00% |
| Aug 2, 23 | 0.04 Increased by +121.05% | -0.13 Increased by +130.77% |
| May 3, 23 | -0.04 Increased by +33.33% | -0.23 Increased by +82.61% |
| Feb 27, 23 | -0.11 Decreased by -650.00% | -0.17 Increased by +35.29% |
| Nov 2, 22 | -0.19 Decreased by -216.67% | -0.25 Increased by +24.00% |
| Aug 3, 22 | -0.19 Decreased by -371.43% | -0.23 Increased by +17.39% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 24 | 143.19 M Increased by +23.27% | -24.20 M Decreased by -991.16% | Decreased by -16.90% Decreased by -785.21% |
| Dec 31, 23 | 132.09 M Increased by +22.57% | -4.67 M Increased by +19.51% | Decreased by -3.53% Increased by +34.33% |
| Sep 30, 23 | 126.37 M Increased by +31.35% | 3.16 M Increased by +131.14% | Increased by +2.50% Increased by +123.71% |
| Jun 30, 23 | 119.00 M Increased by +28.32% | 2.08 M Increased by +120.47% | Increased by +1.75% Increased by +115.95% |
| Mar 31, 23 | 116.17 M Increased by +33.91% | -2.22 M Increased by +30.16% | Decreased by -1.91% Increased by +47.85% |
| Dec 31, 22 | 107.77 M Increased by +29.50% | -5.80 M Decreased by -623.76% | Decreased by -5.38% Decreased by -504.43% |
| Sep 30, 22 | 96.20 M Increased by +31.94% | -10.15 M Decreased by -262.09% | Decreased by -10.55% Decreased by -174.44% |
| Jun 30, 22 | 92.74 M Increased by +46.16% | -10.19 M Decreased by -350.42% | Decreased by -10.98% Decreased by -271.33% |